Savara
Price & Volume
Stats
See more52W Range | $1.89-$7.00 |
Market Cap | $1.1B |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $1,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$83.7M |
Diluted EPS | -$0.53 |
News
See moreYahoo Finance • 19 days ago
Savara Resubmits BLA For MOLBREEVI In Autoimmune PAP
Yahoo Finance • 19 days ago
Savara resubmits MOLBREEVI BLA to FDA, seeks priority review
Yahoo Finance • 2 months ago
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm
Yahoo Finance • 2 months ago
Savara Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SVRA
About
CEO | Mr. Matthew Pauls J.D., M.B.A. |
CFO | Mr. David L. Lowrance CPA |
Address | 1717 Langhorne Newtown Road, Langhorne, PA, United States, 19047 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 59 |
